<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Upregulation of blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> expression causes central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) pharmacoresistance </plain></SENT>
<SENT sid="1" pm="."><plain>However, activation of <z:chebi fb="2" ids="33602">BBB</z:chebi> protein kinase C-β1 (PKC-β1) rapidly reduces basal P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> transport activity </plain></SENT>
<SENT sid="2" pm="."><plain>We tested whether PKC-β1 activation would reverse <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> drug resistance caused by <z:chebi fb="44" ids="28119">dioxin</z:chebi> acting through aryl <z:chebi fb="59" ids="24632">hydrocarbon</z:chebi> receptor </plain></SENT>
<SENT sid="3" pm="."><plain>A selective PKC-β1 agonist abolished the increase in P-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> activity induced by <z:chebi fb="44" ids="28119">dioxin</z:chebi> in isolated rat brain capillaries and reversed the effect of <z:chebi fb="44" ids="28119">dioxin</z:chebi> on brain uptake of <z:chebi fb="1" ids="9948">verapamil</z:chebi> in <z:chebi fb="44" ids="28119">dioxin</z:chebi>-dosed rats </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, targeting <z:chebi fb="2" ids="33602">BBB</z:chebi> PKC-β1 may be an effective strategy to improve drug delivery to the brain, even in drug-resistant individuals </plain></SENT>
</text></document>